Title | Type | SJR | H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 8.793 Q1 | 254 | 32 | 98 | 14357 | 2111 | 98 | 20.53 | 448.66 | |
2 | Medicinal Research Reviews | journal | 3.064 Q1 | 150 | 37 | 112 | 7413 | 1108 | 111 | 9.61 | 200.35 | |
3 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.164 Q1 | 82 | 15 | 42 | 2911 | 243 | 42 | 5.67 | 194.07 | |
4 | Pharmacology and Therapeutics | journal | 4.225 Q1 | 233 | 119 | 320 | 22603 | 3663 | 319 | 12.17 | 189.94 | |
5 | Advances in Molecular Toxicology | book series | 0.322 Q3 | 18 | 8 | 22 | 1420 | 33 | 0 | 0.79 | 177.50 | |
6 | Reviews of Physiology Biochemistry and Pharmacology | journal | 1.777 Q1 | 70 | 6 | 23 | 963 | 127 | 23 | 5.54 | 160.50 | |
7 | Drug Resistance Updates | journal | 3.961 Q1 | 132 | 22 | 45 | 3481 | 503 | 42 | 8.74 | 158.23 | |
8 | Advances in Pharmacology | journal | 1.837 Q1 | 86 | 33 | 120 | 4514 | 451 | 0 | 3.45 | 136.79 | |
9 | Current Drug Metabolism | journal | 0.977 Q2 | 122 | 72 | 301 | 9288 | 1018 | 275 | 3.12 | 129.00 | |
10 | Current Medicinal Chemistry | journal | 0.856 Q2 | 202 | 275 | 1185 | 34914 | 4722 | 1120 | 3.74 | 126.96 | |
11 | Cellular and Molecular Life Sciences | journal | 3.400 Q1 | 261 | 307 | 905 | 38487 | 5684 | 894 | 6.35 | 125.36 | |
12 | Progress in Medicinal Chemistry | journal | 1.504 Q1 | 38 | 6 | 16 | 705 | 71 | 0 | 5.00 | 117.50 | |
13 | Annual Review of Pharmacology and Toxicology | journal | 8.547 Q1 | 224 | 33 | 80 | 3820 | 1457 | 79 | 16.54 | 115.76 | |
14 | Current Pharmaceutical Design | journal | 1.242 Q1 | 183 | 614 | 1877 | 67431 | 6187 | 1727 | 3.19 | 109.82 | |
15 | Current Neuropharmacology | journal | 1.392 Q1 | 103 | 77 | 127 | 8032 | 534 | 118 | 4.09 | 104.31 | |
16 | Current Drug Targets | journal | 1.219 Q1 | 119 | 177 | 486 | 17651 | 1577 | 451 | 3.19 | 99.72 | |
17 | Expert Opinion on Therapeutic Targets | journal | 1.953 Q1 | 106 | 131 | 384 | 12752 | 1802 | 372 | 4.48 | 97.34 | |
18 | Expert Opinion on Emerging Drugs | journal | 1.051 Q2 | 54 | 50 | 125 | 4861 | 374 | 122 | 2.58 | 97.22 | |
19 | Neurotherapeutics | journal | 2.507 Q1 | 136 | 75 | 217 | 7269 | 1247 | 203 | 5.10 | 96.92 | |
20 | Issues in Toxicology | book series | 0.131 Q4 | 18 | 39 | 166 | 3732 | 41 | 152 | 0.22 | 95.69 | |
21 | Current Pharmacology Reports | journal | 35 | 42 | 0 | 3997 | 0 | 0 | 0.00 | 95.17 | ||
22 | Journal of Receptor, Ligand and Channel Research | journal | 0.223 Q3 | 13 | 5 | 13 | 470 | 11 | 13 | 0.64 | 94.00 | |
23 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.134 Q4 | 17 | 25 | 79 | 2307 | 17 | 74 | 0.27 | 92.28 | |
24 | Vaccines | journal | 0.882 Q2 | 85 | 51 | 44 | 4651 | 82 | 42 | 1.86 | 91.20 | |
25 | Current Molecular Pharmacology | journal | 1.354 Q1 | 49 | 35 | 77 | 3169 | 231 | 67 | 2.03 | 90.54 | |
26 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.264 Q3 | 29 | 8 | 35 | 717 | 42 | 0 | 1.59 | 89.63 | |
27 | Trends in Pharmacological Sciences | journal | 5.367 Q1 | 244 | 92 | 261 | 7981 | 2758 | 212 | 10.17 | 86.75 | |
28 | Current Cancer Drug Targets | journal | 1.569 Q1 | 103 | 74 | 236 | 6413 | 960 | 224 | 4.16 | 86.66 | |
29 | Clinical Medicine Insights: Therapeutics | journal | 0.186 Q4 | 11 | 8 | 39 | 684 | 19 | 39 | 0.76 | 85.50 | |
30 | Expert Review of Vaccines | journal | 1.772 Q1 | 105 | 107 | 459 | 9145 | 1608 | 408 | 3.46 | 85.47 | |
31 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.865 Q2 | 100 | 148 | 382 | 12625 | 1188 | 379 | 3.07 | 85.30 | |
32 | Expert Opinion on Investigational Drugs | journal | 1.341 Q1 | 117 | 132 | 440 | 11218 | 1719 | 434 | 3.84 | 84.98 | |
33 | Biomarker Insights | journal | 0.800 Q2 | 40 | 68 | 45 | 5487 | 111 | 44 | 1.83 | 80.69 | |
34 | Journal of Experimental Pharmacology | journal | 0.323 Q3 | 23 | 4 | 4 | 322 | 9 | 4 | 3.00 | 80.50 | |
35 | Mini-Reviews in Medicinal Chemistry | journal | 0.437 Q3 | 107 | 118 | 399 | 9356 | 1258 | 384 | 3.12 | 79.29 | |
36 | British Journal of Pharmacology | journal | 2.374 Q1 | 244 | 442 | 1416 | 34860 | 7464 | 1388 | 5.48 | 78.87 | |
37 | Side Effects of Drugs Annual | book series | 0.101 Q4 | 9 | 49 | 161 | 3827 | 5 | 4 | 0.02 | 78.10 | |
38 | Current Vascular Pharmacology | journal | 0.897 Q2 | 69 | 96 | 310 | 7129 | 720 | 268 | 2.21 | 74.26 | |
39 | Pharmacological Research | journal | 2.143 Q1 | 169 | 204 | 370 | 15131 | 2201 | 363 | 6.52 | 74.17 | |
40 | Expert Opinion on Therapeutic Patents | journal | 1.081 Q2 | 88 | 114 | 314 | 8332 | 1340 | 313 | 4.59 | 73.09 | |
41 | Frontiers in Pharmacology | journal | 1.886 Q1 | 154 | 303 | 628 | 22107 | 2862 | 592 | 4.48 | 72.96 | |
42 | Expert Opinion on Biological Therapy | journal | 1.180 Q1 | 102 | 177 | 508 | 12702 | 1830 | 494 | 3.67 | 71.76 | |
43 | CNS and Neurological Disorders - Drug Targets | journal | 0.894 Q2 | 96 | 164 | 459 | 11343 | 1066 | 404 | 2.23 | 69.16 | |
44 | Journal of Psychopharmacology | journal | 1.775 Q1 | 135 | 128 | 439 | 8796 | 1837 | 412 | 3.95 | 68.72 | |
45 | Journal of NeuroImmune Pharmacology | journal | 1.716 Q1 | 91 | 62 | 259 | 4238 | 1027 | 247 | 4.16 | 68.35 | |
46 | Current Pharmacogenomics and Personalized Medicine | journal | 0.174 Q4 | 20 | 25 | 95 | 1706 | 40 | 79 | 0.43 | 68.24 | |
47 | Expert Opinion on Pharmacotherapy | journal | 0.907 Q2 | 93 | 251 | 734 | 17110 | 2183 | 705 | 3.15 | 68.17 | |
48 | Neuropharmacology | journal | 2.547 Q1 | 191 | 371 | 1266 | 25215 | 7284 | 1244 | 5.44 | 67.96 | |
49 | Behavioural Pharmacology | journal | 0.881 Q2 | 87 | 83 | 241 | 5623 | 570 | 238 | 2.26 | 67.75 | |
50 | Future Medicinal Chemistry | journal | 0.825 Q2 | 90 | 187 | 568 | 12466 | 1450 | 447 | 2.21 | 66.66 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®